Is it Rational to Continue Anti-Neoplastics with Minimal Toxicity even after Progression in Patients with no other Options? Possibly Yes

Basit Öğe Kaydı
dc.authoridsezer, ahmet/0000-0002-6445-1439
dc.authoridSumbul, Ahmet Taner/0000-0002-5573-906X
dc.contributor.authorSezer, Ahmet
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorAbali, Huseyin
dc.date.accessioned2024-09-18T21:06:43Z
dc.date.available2024-09-18T21:06:43Z
dc.date.issued2014
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.7314/APJCP.2014.15.2.1061
dc.identifier.endpage1062en_US
dc.identifier.issn1513-7368
dc.identifier.issue2en_US
dc.identifier.pmid24568451en_US
dc.identifier.scopus2-s2.0-84894646428en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1061en_US
dc.identifier.urihttps://doi.org/10.7314/APJCP.2014.15.2.1061
dc.identifier.urihttps://hdl.handle.net/20.500.12483/13785
dc.identifier.volume15en_US
dc.identifier.wosWOS:000332517500088en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAsian Pacific Organization Cancer Preventionen_US
dc.relation.ispartofAsian Pacific Journal of Cancer Preventionen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleIs it Rational to Continue Anti-Neoplastics with Minimal Toxicity even after Progression in Patients with no other Options? Possibly Yesen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu